Success Metrics

Active Trials
1(50%)

Phase Distribution

Ph phase_4
1
50%
Ph early_phase_1
1
50%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (50.0%)
Phase 41 (50.0%)

Trials by Status

not_yet_recruiting150%
recruiting150%

Recent Activity

1 active trials
Showing 2 of 2
not_yet_recruitingphase_4

SGLT2i Therapy in Islet Transplantation (SIT)

NCT07228195
recruitingearly_phase_1

Ketones, SGLT2, HFrEF

NCT06229678

Clinical Trials (2)

Showing 2 of 2 trials
NCT07228195Phase 4

SGLT2i Therapy in Islet Transplantation (SIT)

Not Yet Recruiting
NCT06229678Early Phase 1

Ketones, SGLT2, HFrEF

Recruiting

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2